SUMO2 and frontotemporal dementia: When assessing the interaction between TDP-43 and SUMO2/3, we observed a significant increase in interactions in the prefrontal cortex of ALS/FTD patients with TDP-43 pathology suggesting the TDP-43 SUMOylation pathway is engaged in disease (Fig. 6C, Fig. S13B).